These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 23335551)

  • 1. Design of a novel class of protein-based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkers.
    Xue S; Qiao J; Pu F; Cameron M; Yang JJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(2):163-79. PubMed ID: 23335551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein MRI Contrast Agents as an Effective Approach for Precision Molecular Imaging.
    Li D; Kirberger M; Qiao J; Gui Z; Xue S; Pu F; Jiang J; Xu Y; Tan S; Salarian M; Ibhagui O; Hekmatyar K; Yang JJ
    Invest Radiol; 2024 Feb; 59(2):170-186. PubMed ID: 38180819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of ProCAs (protein-based Gd(3+) MRI contrast agents) with high dose efficiency and capability for molecular imaging of cancer biomarkers.
    Xue S; Qiao J; Jiang J; Hubbard K; White N; Wei L; Li S; Liu ZR; Yang JJ
    Med Res Rev; 2014 Sep; 34(5):1070-99. PubMed ID: 24615853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards the Molecular Imaging of Prostate Cancer Biomarkers Using Protein-based MRI Contrast Agents.
    Pu F; Xue S; Qiao J; Patel A; Yang JJ
    Curr Protein Pept Sci; 2016; 17(6):519-33. PubMed ID: 26721404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GRPR-targeted Protein Contrast Agents for Molecular Imaging of Receptor Expression in Cancers by MRI.
    Pu F; Qiao J; Xue S; Yang H; Patel A; Wei L; Hekmatyar K; Salarian M; Grossniklaus HE; Liu ZR; Yang JJ
    Sci Rep; 2015 Nov; 5():16214. PubMed ID: 26577829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemistry of tumour targeted T1 based MRI contrast agents.
    Kamaly N; Miller AD; Bell JD
    Curr Top Med Chem; 2010; 10(12):1158-83. PubMed ID: 20388110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
    Caravan P
    Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular imaging of EGFR/HER2 cancer biomarkers by protein MRI contrast agents.
    Qiao J; Xue S; Pu F; White N; Jiang J; Liu ZR; Yang JJ
    J Biol Inorg Chem; 2014 Feb; 19(2):259-70. PubMed ID: 24366655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Polypeptide-Based, Membrane-Penetrating, Target-Specific Contrast Agent for Magnetic Resonance Molecular Imaging.
    Yu K; Yu Y; Yao Y; Wu Z; Fu S; Cheng RH; Chen YW; Chen HY; Zhou J; Hwang DW; Ding S
    ACS Appl Bio Mater; 2021 Feb; 4(2):1597-1604. PubMed ID: 35014508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gd-hydroxypyridinone (HOPO)-based high-relaxivity magnetic resonance imaging (MRI) contrast agents.
    Datta A; Raymond KN
    Acc Chem Res; 2009 Jul; 42(7):938-47. PubMed ID: 19505089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
    Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
    Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
    [No Abstract]   [Full Text] [Related]  

  • 12. Gadolinium-based contrast agents for magnetic resonance cancer imaging.
    Zhou Z; Lu ZR
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(1):1-18. PubMed ID: 23047730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of colonic dysplasia by magnetic resonance molecular imaging with a contrast agent raised against the colon cancer marker MUC5AC.
    Rossez Y; Burtea C; Laurent S; Gosset P; Léonard R; Gonzalez W; Ballet S; Raynal I; Rousseaux O; Dugué T; Vander Elst L; Michalski JC; Muller RN; Robbe-Masselot C
    Contrast Media Mol Imaging; 2016 May; 11(3):211-21. PubMed ID: 26762591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-Microenvironment Relaxivity-Changeable Gd-Loaded Poly(L-lysine)/Carboxymethyl Chitosan Nanoparticles as Cancer-Recognizable Magnetic Resonance Imaging Contrast Agents.
    Jiang D; Zhang X; Yu D; Xiao Y; Wang T; Su Z; Liu Y; Zhang N
    J Biomed Nanotechnol; 2017 Mar; 13(3):243-54. PubMed ID: 29381026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclen-based Gd
    Rashid HU; Martines MAU; Jorge J; de Moraes PM; Umar MN; Khan K; Rehman HU
    Bioorg Med Chem; 2016 Nov; 24(22):5663-5684. PubMed ID: 27729196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current limitations of molecular magnetic resonance imaging for tumors as evaluated with high-relaxivity CD105-specific iron oxide nanoparticles.
    Dassler K; Roohi F; Lohrke J; Ide A; Remmele S; Hütter J; Pietsch H; Pison U; Schütz G
    Invest Radiol; 2012 Jul; 47(7):383-91. PubMed ID: 22659596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
    Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J
    Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadolinium chelate with DO3A conjugated 2-(diphenylphosphoryl)-ethyldiphenylphosphonium cation as potential tumor-selective MRI contrast agent.
    Chandrasekharan P; Yong CX; Poh Z; He T; He Z; Liu S; Robins EG; Chuang KH; Yang CT
    Biomaterials; 2012 Dec; 33(36):9225-31. PubMed ID: 23026708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of a modular protein-based MRI contrast agent for targeted application.
    Grum D; Franke S; Kraff O; Heider D; Schramm A; Hoffmann D; Bayer P
    PLoS One; 2013; 8(6):e65346. PubMed ID: 23762349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-EpCAM scFv gadolinium chelate: a novel targeted MRI contrast agent for imaging of colorectal cancer.
    Khantasup K; Saiviroonporn P; Jarussophon S; Chantima W; Dharakul T
    MAGMA; 2018 Oct; 31(5):633-644. PubMed ID: 29737435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.